NEW YORK (GenomeWeb News) — Software company InforSense said today that it has received a $5 million financing commitment from existing investors, and that company founder Yike Guo will be stepping down from the CEO position to serve as chief technology officer and head of innovation.

David Bennett, who joined the company in January 2008 as executive vice president of worldwide sales, has been appointed the company's new CEO, effective immediately.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.